Status:
UNKNOWN
Sodium Glucose Cotransporter-2 Inhibitors and Salt-sensitivity in Type 2 Diabetes
Lead Sponsor:
Azienda Ospedaliero, Universitaria Pisana
Collaborating Sponsors:
European Foundation for the Study of Diabetes
Conditions:
Blood Pressure
Salt; Excess
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The goal of this interventional study is to test whether sodium-glucose cotransporter 2 inhibitors (SGLT2i) reduce the effects of high dietary sodium intake in patients with type 2 diabetes. Particip...
Eligibility Criteria
Inclusion
- age 18-65 years;
- both males and females;
- type 2 diabetes.
Exclusion
- type 1 diabetes;
- insulin treatment;
- uncontrolled hypertension (SBP \> 160 mmHg and/or DBP \>95 mmHg);
- pregnancy;
- other acute or chronic conditions influencing blood pressure and glucose metabolism.
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06007157
Start Date
March 1 2023
End Date
March 1 2025
Last Update
August 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliero-Universitaria Pisana
Pisa, PI, Italy, 56127